Biotech Corridor event focuses on industry challenges
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Cognixion’s flagship product receives FDA breakthrough designation
Santa Barbara-based Cognixion has received a Breakthrough Device designation from the U.S. Food and Drug Administration, the company announced on May 4, paving the way to get its artificial intelligence-powered neural interface to the market faster. Cognixion was founded in 2014 by Andreas Forsland, under the name Smartstone at the time. With the designation, Cognixion Read More →
Biosimilar market continues cutting into Amgen’s top line
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
CRELY leverages AI to change the healthcare industry
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s revenue dips in the first quarter, still beats earnings estimates
Thousand Oaks-based Amgen delivered a sound earnings beat in the first quarter of 2023, the company announced after the markets closed on April 27. Amgen, one of the largest biotechnology companies in the world, generated net income worth $2.8 billion in the first quarter or $5.28 earnings per share. This nearly doubled last year’s first-quarter Read More →
Aptitude receives $54 million for diagnostic platform
COVID is transitioning from a pandemic state to an endemic one and as a result, life is returning more and more back to normal. Businesses are open, gatherings are no longer discouraged and people can enjoy many of the activities they enjoyed before 2020. But while it may not be a pandemic anymore, tracking COVID Read More →
Teledyne starts the new year strong with earnings beat
Thousand Oaks-based Teledyne Technologies kicked off the earnings season right here on the Central Coast, delivering an earnings and revenue beat for the first quarter of 2023, the company announced on April 26 before the markets opened. Teledyne, a technology and defense conglomerate, delivered record revenue results in the first quarter, generating $1.38 billion in Read More →
